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roundworm Caenorhabditis elegans and are capable of producing essential omega-6 and omega-3 fatty acids from saturated
fats or carbohydrates. When maintained on a high-saturated fat diet lacking essential fatty acids or a high-carbohydrate, no-
fat diet, the Omega mice exhibit high tissue levels of both omega-6 and omega-3 fatty acids, with a ratio of ,1:1. This study
thus presents an innovative technology for the production of both omega-6 and omega-3 essential fatty acids, as well as a
new animal model for understanding the true impact of fat on human health.
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Introduction
There are several classes of fats that differentially affect human
health, such as saturated fatty acids (SFA), monounsaturated fatty
acids (MUFA), and polyunsaturated fatty acids (PUFA), including
both essential omega-6 (n-6) and omega-3 (n-3) PUFA. Recent
research has shown that our health is impacted not just by the
quantity of fat consumed, but more significantly by the types of fat
consumed [1],[2]. For example, the worldwide trend of increased
SFA and n-6 PUFA intake and decreased n-3 PUFA intake has
coincided with the growing prevalence of chronic diseases, such as
heart disease, cancer, Alzheimer’s, and diabetes [2].
Normally, mammals readily obtain SFA from either the diet or
endogenous synthesis from glucose or amino acids [3], and MUFA
can also be obtained from the diet or converted from SFA by the
stearoyl-CoA desaturase-1 (SCD-1) gene [4]. On the other hand,
n-6 and n-3 PUFA cannot be inter-converted or synthesized de novo
in mammals and are mainly acquired through the diet [5]. The
primary essential fatty acids in the diet are n-6 linoleic acid (18:2n-
6, LA) and n-3 a-linolenic acid (18:3n-3, ALA), which can be
converted into longer-chain n-6 PUFA arachidonic acid (20:4n-6,
AA) and n-3 PUFA eicosapentaenoic acid (20:5n-3, EPA) and
docosahexaenoic acid (22:6n-3, DHA), respectively, through a
series of desaturation and chain-elongation enzyme systems [5].
The metabolites derived from n-6 and n-3 PUFA, namely
eicosanoids, are functionally distinct and have important opposing
physiological effects [6]. For example, n-6-derived eicosanoids
generally promote inflammation, while n-3-derived eicosanoids
have anti-inflammatory properties. Since the synthesis of n-6 and
n-3 long-chain PUFA and their metabolites compete for the same
enzymes, their ratio in body tissues determines the eicosanoid
profile. Recent studies have indicated that the tissue n-6/n-3
PUFA ratio plays an important role in the pathogenesis of many
chronic diseases [2],[7]. Many global health organizations now
recommend an increased daily intake of n-3 PUFA, particularly
EPA and DHA, but these n-3 PUFA are largely limited to marine
sources (such as fish and algae) that can be less affordable or
accessible [8]. Thus, it is often challenging to balance the different
types of dietary fat in a way that optimizes health.
Unlike mammals, the roundworm C. elegans is capable of
producing all classes of fatty acids as they possess the required
genes. For example, the fat-2 gene encodes a desaturase that
catalyzes the conversion of MUFA to n-6 PUFA, and the fat-1
gene enables the conversion of n-6 to n-3 PUFA [9]. Our
laboratory previously created the fat-1 transgenic technology to
express the fat-1 gene in mammals (both mice and livestock), which
successfully demonstrated the conversion of dietary n-6 to n-3
PUFA and exhibited a balanced n-6/n-3 PUFA ratio in body
tissues, regardless of diet [10],[11]. Our earlier work generated a
unique fat-1 mouse model for n-3 PUFA research and also
provided a sustainable, land-based strategy for the production of
n-3 PUFA from n-6 PUFA [12],[13],[14].
The objective of this study was to generate a novel transgenic
mouse model that can endogenously synthesize all essential fatty
acids. Our strategy was to first create a fat-2 transgenic mouse,
possessing the C. elegans fat-2 gene encoding an enzyme that
converts MUFA into n-6 LA [9], and then cross the fat-2
transgenic mice with fat-1 transgenic mice, which we generated
previously to possess the C. elegans fat-1 gene, encoding an enzyme
that converts n-6 to n-3 PUFA [10]. Through this procedure, we
can generate a compound fat-1/fat-2 transgenic mouse – hereafter
PLOS ONE | www.plosone.org 1 May 2014 | Volume 9 | Issue 5 | e97637Transgenic Production of Essential Fatty Acids
PLOS ONE | www.plosone.org 2 May 2014 | Volume 9 | Issue 5 | e97637referred to as the ‘‘Omega’’ mouse – that is capable of producing
both n-6 and n-3 PUFA from a diet containing only saturated fat
or carbohydrates (Figure 1A).
Results and Discussion
To enable the higher expression of the C. elegans fat-2 gene in
mammals, we first optimized the codon of the fat-2 sequence based
on the mammalian desaturase sequence (Figure S1) and utilized a
chicken beta-actin promoter to build a transgene construct
(Figure S2), and then used microinjection to create the fat-2
transgenic mouse. After the fat-2 phenotype and genotype were
confirmed, the heterozygous fat-2 transgenic mice were back-
crossed with C57BL6 wild-type (WT) mice for 5 generations, and
then crossbred with heterozygous fat-1 transgenic mice. The
resulting offspring consisted of WT, fat-1, fat-2, and Omega mice.
The fat-1 mouse phenotype has been reported previously
[7],[10],[12]. Expression of the fat-1 and fat-2 transgenes was
validated by PCR, confirming that WT mice do not express any of
the transgenes, the fat-2 mice carry only the fat-2 transgene, and
the Omega mice express both the fat-1 and fat-2 transgenes
(Figure 1B).
When WT, fat-1, fat-2, and Omega mouse littermates were fed
the same diet high in saturated fat and carbohydrates and low in n-
6 PUFA (Table S1), phenotype validation by gas chromatography
(GC) revealed four distinct tissue fatty acid profiles (Tables 1 and
2). The difference in fatty acid profiles for the new fat-2 and
Omega mice are highlighted in Figure 1C and D. As expected,
the WT mice exhibited high levels of saturated fat and very low
levels of essential fatty acids, primarily n-6 PUFA, with an n-6/n-3
PUFA ratio of roughly 3.5. The fat-2 transgenic mice displayed a
significant increase in total tissue PUFA content, with the n-6
PUFA content in the muscle tissue doubling from about 700 mg/g
to 1350 mg/g due to the conversion of oleic acid into n-6 LA and
AA, without much change in n-3 PUFA levels, resulting in an n-6/
n-3 PUFA ratio of about 5. The Omega transgenic mice also
Figure 1. Generation, genotyping, and phenotyping of the fat-2 and Omega transgenic mice. (A) Roadmap for the conversion of essential
fatty acids from non-essential nutrients in Omega mice. In mammals, carbohydrates can be converted to SFA, and SFA can be converted into MUFA
by SCD-1. Introduction of the fat-2 and fat-1 transgenes allows mammals to further convert MUFA into n-6 PUFA, and n-6 PUFA into n-3 PUFA,
respectively. (B) Validation of fat-1 and fat-2 transgene expression in wild-type (WT), fat-2, and Omega mouse littermates by PCR. (C) Partial gas
chromatograph traces showing the fatty acid profiles of total lipids extracted from skeletal muscles of a wild-type mouse (WT, upper panel), a fat-2
transgenic mouse (Fat-2, middle panel), and an Omega transgenic mouse (Omega, lower panel). All mice were 10-week-old males and fed with the
same diet high in SFA and carbohydrates and low in n-6 PUFA. (D) Quantification of PUFA from muscle tissue of WT, fat-2, and Omega mice (left). For
significance values, refer to Table 1 and Table S2. Comparison of the n-6/n-3 PUFA ratio among the phenotypes (right). Values expressed as mean
6 s.d. (n=3 per group; *P,0.05, **P,0.01).
doi:10.1371/journal.pone.0097637.g001
Table 1. Comparison of the fatty acid profiles of various tissues among the four genotypes.
Muscle
SFA MUFA Total PUFA n-6 PUFA n-3 PUFA n-6/n-3
WT 38.9660.98 42.8761.99
##gg 18.1961.29
##gg 14.2361.59
## 3.9660.48
gg 3.6060.95
gg
Fat-1 40.5160.35 42.2861.81
mm** 16.8961.55
mm** 6.2361.16
mm** 10.6660.76
mm** 0.5960.10
mm
Fat-2 41.1562.02 29.7162.13
##mm 29.0160.99
##wmm 24.2960.93
##wwmm 4.7260.40
wwmm 5.1860.52
wwmm
Omega 41.0860.47 33.0362.12
gg** 25.9061.95
ggw** 11.2362.43
ww** 14.6762.09
ggww** 0.7860.24
ggww
Liver
SFA MUFA Total PUFA n-6 PUFA n-3 PUFA n-6/n-3
WT 36.7060.83 48.7861.00
##gg 14.4461.32
##gg 11.8661.33
##gg 2.5760.07
#gg 4.6260.55
##gg
Fat-1 37.4961.27 49.3860.72
mm** 13.1660.77
mm** 7.2860.58
mm** 5.8860.40
mm** 1.2460.11
mm
Fat-2 37.3362.25 33.8763.05
##mm 28.8261.55
##mm 25.0361.69
##wwmm 3.7860.29
#wwmm 6.6560.82
##wwmm
Omega 37.9062.09 34.2163.75
gg** 27.9062.50
gg** 17.3861.76
ggww** 10.5260.74
ggww** 1.6560.05
ggww
Tail
SFA MUFA Total PUFA n-6 PUFA n-3 PUFA n-6/n-3
WT 29.4161.55 62.3962.19
##gg 8.2060.63
##gg 7.2760.41
##g 0.9360.23
gg 8.0761.38
##gg
Fat-1 26.9961.0
m* 64.9661.38
mm** 8.0560.38
mm** 2.4960.32
mm** 5.5560.70
mm** 0.4660.11
mm
Fat-2 33.1663.42
m 47.6563.55
##mm 19.2061.57
##mm 17.8561.50
##wwmm 1.3560.33
wwmm 13.8163.87
##wwmm
Omega 32.7962.73* 49.0262.15
gg** 18.2061.18
gg** 10.1661.62
gww** 8.0460.44
ggww** 1.2760.27
ggww
The four genotypes of mice were fed the same low-PUFA diet for about two months and tissue samples were subject to lipid analysis by gas chromatography. WT: Wild-
type; SFA: saturated fatty acids; MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids; n-6: omega-6; n-3: omega-3; n=3 for each group;
(WT vs Fat-1),
#(WT vs Fat-2),
g(WT vs Omega),
m(Fat-1 vs Fat-2),
*(Fat-1 vs Omega),
w(Fat-2 vs Omega), One symbol =P,0.05, Two symbols =P,0.01.
doi:10.1371/journal.pone.0097637.t001
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content of n-3 PUFA was increased by roughly five-fold compared
to their WT and fat-2 littermates, due to the conversion of almost
half the n-6 PUFA content into n-3 PUFA, with a markedly
decreased n-6/n-3 PUFA ratio of 0.75 (Figure 1D). MUFA levels
were accordingly reduced in the fat-2 and Omega mice, showing
that n-6 PUFA had been converted from MUFA. No significant
differences in SFA levels were observed among the phenotypes.
Detailed fatty acid profiles for the four genotypes (WT, fat-1, fat-2,
and Omega) are shown in Tables S2–5. Furthermore, when fed a
high-carbohydrate, no-fat diet (Table S1), the fat-2 and Omega
mice still exhibited significant tissue levels of n-6 and n-3 PUFA,
respectively, confirming their ability to produce essential fatty
acids when lacking dietary fat and given only carbohydrates
(Table 2). The tissue abundance of n-6 PUFA in the fat-2 mouse
and of both n-3 and n-6 PUFA in the Omega mouse, despite the
diet containing little of these fatty acids, thus demonstrates the
capability of our transgenic mice to produce essential fatty acids
from non-essential nutrients – MUFA, SFA, and even carbohy-
drates.
The Western human diet today is fundamentally different than
it was throughout the majority of human evolution. Among the
many shifts in dietary nutrients that have occurred over the last
few decades, key changes include increases in saturated fat,
carbohydrates, and n-6 PUFA intake with a decrease in n-3 PUFA
intake [15],[16],[17]. As a result, modern humans have an n-6 to
n-3 PUFA ratio that favors n-6 PUFA by as much as 20:1;
evolutionarily, this ratio would have been closer to 1:1, and the
discrepancy is thought to have profound physiological conse-
quences [15],[16]. This study presents a new transgenic technol-
ogy that could produce essential fatty acids, especially the
beneficial n-3 PUFA, in animal products (such as meat, milk,
eggs, etc.) by feeding animals with just carbohydrates and/or
saturated fat. Given that n-3 PUFA are largely limited to marine
sources (such as fish and algae), this technology could therefore
generate sustainable and accessible n-3 PUFA resources, especially
where only carbohydrates are available.
The transgenic technology presented in this study will also be of
great utility in elucidating the impact of essential fatty acids on
health. Conventionally, dietary modification is used to investigate
the effects of different fatty acid profiles, which requires feeding
animals with different diets. However, this method is problematic
since the diets may not only contain different fatty acid
compositions, but also variations in impurities, flavor, calories,
or other components used between study groups, ultimately
leading to confounding factors that complicate interpretation of
results. Our transgenic technology allows us to create four different
tissue fatty acid profiles by using a single diet, which makes it
possible to evaluate the true health effects of different fats without
the confounding factors of diet. This is very important for
identification of metabolic biomarkers related to lipid metabolism.
This study clearly demonstrates the feasibility of producing
mammals with the capability to convert SFA and MUFA to the
essential n-6 and n-3 PUFA. The transgenic mice created by this
project will serve as unique animal models, free of dietary
confounding factors, for the reliable study of the biological effects
of different fatty acid profiles. Ultimately, this transgenic
technology serves as a new biotechnology for the production of
essential fatty acids, especially n-3 EPA and DHA, to meet
increasing demand.
Materials and Methods
Ethics statement
All animal procedures in this study were reviewed and approved
by the Massachusetts General Hospital (MGH) Subcommittee on
Research Animal Care (SRAC).
Codon optimization
In order to efficiently express a gene from the lower-life C.
elegans in mammals in vivo, the codon usage by C. elegans must be
adjusted to match those used by mammals. The fat-2 gene
sequence was obtained from the gene bank (GenBank accession
number NM_070159). We used mammalian desaturases as well as
our previously optimized fat-1 gene as references to determine the
differences in codon usages of desaturases between C. elegans and
mammals. We then manually adjusted the codon to achieve over
80% optimization (Figure S1).
Gene synthesis
After modifying the gene sequence to optimize the codon usage,
the fat-2 gene was synthesized by GenScript (Piscataway, NJ). The
gene was synthesized to be flanked with EcoR I digestion sites and
delivered on pUC57 plasmid. After amplification, the fat-2
sequence was inserted into a pCAGGS expression plasmid
containing the chicken beta-actin promoter and cytomegalovirus
enhancer (kindly provided by Dr. J Miyazaki, Osaka University
Medical School). After ligation, the orientation was confirmed and
the plasmid was amplified. Finally, the fragment containing the
Table 2. Fatty acid profile of tail tissue from mice fed with a high-carbohydrate, no-fat diet.
SFA MUFA Total PUFA n-6 PUFA n-3 PUFA n-6/n-3
WT 28.8567.64 64.0968.13 7.0660.89
##gg 6.460.75
##gg 0.6660.14
gg 9.9361.2
##gg
Fat-1 28.2460.33 65.4661.05
m* 6.3260.71
mm** 2.3260.38
mm** 460.66
mm** 0.5960.16
mm
Fat-2 27.7861.56 57.1462.01
m 15.160.65
##mm 14.4460.74
##wwmm 0.6560.09
wwmm 22.4463.82
##wwmm
Omega 29.0663.43 56.9862.65* 13.9760.78
gg** 8.8260.75
ggww** 5.1660.28
ggww** 1.7160.18
ggww
The four genotypes of mice were fed the same no-fat diet for about two months and tail tissue was subject to lipid analysis by gas chromatography. WT: Wild-type; SFA:
saturated fatty acids; MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids; n-6: omega-6; n-3: omega-3; n=3 for each group;
(WT vs Fat-1),
#(WT vs Fat-2),
g(WT vs Omega),
m(Fat-1 vs Fat-2),
*(Fat-1 vs Omega),
w(Fat-2 vs Omega), One symbol =P,0.05, Two symbols =P,0.01.
doi:10.1371/journal.pone.0097637.t002
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with SspI and Sfi I for microinjection (Figure S2).
Microinjection
Transgenic mouse lines were produced at the MGH Transgenic
Core Facility by injecting the purified Ssp I and Sfi I fragment into
fertilized eggs from C57BL/6 X C3H mice. The fertilized eggs
containing the transgene were transferred to pseudo-pregnant
mice (B6CF1) to produce transgenic mice. The founder transgenic
mice were then subjected to genotyping and phenotyping.
Genotyping and phenotyping
Genotyping was carried out by removing the tip of the tail to
acquire a DNA sample for RT-PCR, which was performed with
the following primers: fat-2 forward, GCGGCCA GACCCA-
GACCATC; and fat-2 reverse, GGGCGAC
GTGACCGTTGGTA. PCR products were run through gel
electrophoresis on 2% agarose gel. Phenotyping by fatty acid
composition analysis using gas chromatography (GC) was
performed as previously described [18]. The fat-2 mice were
maintained after weaning on a low-PUFA diet (Table S1). GC
was carried out after 20 days on the diet to allow for clearer
phenotypes. Tissue samples were ground to powder under liquid
nitrogen and total lipids were extracted using chloroform/
methanol (2:1, v/v). Fatty acids were then methylated by heating
them at 100uC for 1 hour under 14% boron trifluoride (BF3)-
methanol reagent (Sigma-Aldrich, St. Louis, MO) and hexane
(Sigma-Aldrich). Fatty acid methyl esters were analyzed by GC
using a fully automated 6890N Network GC System (Agilent
Technologies, Santa Clara, CA) equipped with a flame-ionization
detector and an Omegawax 250 capillary column
(30 m60.25 mm ID). Fatty acid standards (Nu-chek-Prep, Elysian,
MN) were used to identify peaks of resolved fatty acids, and area
percentages for all resolved peaks were analyzed using GC
ChemStation Software (Agilent). The fatty acid C23:0 (20 mg/
sample) was used as an internal standard to calculate the amount
of each fatty acid measured.
After identifying the genotype and phenotype, the fat-2 mice
were mated with WT C57BL6 mice to create the F1 generation.
The F1 generation was then backcrossed with WT C57BL6 mice
at least 5 times in order to verify that the gene is transmittable as
well as to establish a pure background, so that fat-2 lines could be
maintained with a significant phenotype. Each generation was
subjected to genotyping by RT-PCR and phenotyping by GC.
Generation of Omega mice
The compound fat-1/fat-2 transgenic mice were created by
crossbreeding heterozygous fat-2 transgenic mice with heterozy-
gous fat-1 transgenic mice, which were previously generated by
our group [10]. After weaning, the offspring were maintained
either on low-PUFA diet or a no-fat diet (Table S1), and then
genotyped by RT-PCR and phenotyped by GC. Genotyping by
RT-PCR of the Omega mice was carried out with the following
primers: fat-1 forward, TGTTCATGCCTTCT TCTTTTTCC;
fat-1 reverse, GCGACCATACC TCAAACTTGGA; fat-2 for-
ward, GCGGCCA GACCCAGACCATC; fat-2 reverse,
GGGCGAC GTGACCGTTGGTA. Phenotyping by fatty acid
composition analysis using GC was performed as previously
described [18].
Statistical analysis
GraphPad Prism 5 (GraphPad Software, San Diego, CA) was
used for all statistical analyses. Data sets were analyzed by F-test to
verify normal distribution. One-way ANOVA followed by the
Tukey test was used to determine statistical significance, set at *P,
0.05 and **P,0.01.
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